{"url_path":"/sec/smnrw/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1913577/0001193125-26-221896-index.html","accession_number":"0001193125-26-221896","cik":"0001913577","ticker":"SMNR","issuer_name":"Semnur Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1913577/0001193125-26-221896-index.html","primary_entity_key":"0001913577","primary_entity_name":"Semnur Pharmaceuticals, Inc."},"word_count":519,"has_tables":true,"body_markdown":"10-Q\n\nQ1--12-310001913577falseSeptember 30, 2027http://fasb.org/srt/2025#ChiefExecutiveOfficerMember150001913577smnr:StockBasedCompensationMembersmnr:ScilexHoldingCompanyMember2026-01-012026-03-310001913577smnr:LegacySemnurCommonStockMember2026-01-012026-03-310001913577us-gaap:CommonStockMembersmnr:ConsultingServicesAgreementWithJWInvestmentManagementCompanyLimitedMember2026-01-012026-03-310001913577us-gaap:PreferredStockMember2025-01-012025-03-310001913577smnr:DenaliUnderwriterNotesMember2026-01-012026-03-310001913577us-gaap:CommonStockMember2025-12-310001913577us-gaap:FurnitureAndFixturesMember2025-12-310001913577smnr:CumulativeNetSalesTwoHundredAndFiftyMillionDollarsMembersmnr:LegacySemnurMergerAgreementMember2019-03-182019-03-180001913577smnr:DenaliUnderwriterNotesMembersmnr:SatisfactionAndDischargeOfIndebtednessAgreementMember2026-03-310001913577smnr:ShahAssignmentAgreementMembersmnr:NetSalesForAnnualNetSalesAtTheRateOfOnePointFivePercentageMember2013-08-062013-08-060001913577smnr:TwoThousandTwentyFourStockOptionPlanMember2026-01-012026-03-310001913577smnr:SeniorSecuredPromissoryNoteMembersmnr:ScilexOramedSPAMember2023-09-212023-09-210001913577us-gaap:RetainedEarningsMember2024-12-310001913577us-gaap:EmployeeStockOptionMember2025-01-012025-03-310001913577us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001913577us-gaap:AdditionalPaidInCapitalMember2024-12-310001913577smnr:LegacySemnurCommonStockMember2024-12-310001913577smnr:MergerAgreementMembersmnr:ScilexHoldingCompanyMember2025-09-222025-09-220001913577smnr:FutureTechNoteMember2026-03-310001913577us-gaap:RetainedEarningsMember2025-12-310001913577us-gaap:PreferredStockMember2026-03-310001913577smnr:ScilexHoldingCompanyMembersmnr:DebtExchangeAgreementMember2025-09-222025-09-220001913577us-gaap:CommonStockMember2026-01-012026-03-310001913577us-gaap:SeriesAPreferredStockMembersmnr:DebtExchangeAgreementMembersmnr:ScilexHoldingCompanyMember2024-08-302024-08-300001913577us-gaap:RetainedEarningsMember2026-01-012026-03-310001913577us-gaap:FurnitureAndFixturesMember2026-03-310001913577smnr:LegacySemnurCommonStockMember2025-01-012025-03-310001913577smnr:TwoThousandTwentyFiveEmployeeStockPurchasePlanMember2025-11-170001913577smnr:ScilexHoldingCompanyMembersmnr:DebtExchangeAgreementMembersmnr:LegacySemnurSeriesAPreferredStockMember2025-09-222025-09-220001913577us-gaap:CommonClassBMember2026-03-310001913577smnr:FutureTechNoteMember2026-01-012026-03-310001913577us-gaap:PreferredStockMembersrt:RestatementAdjustmentMember2024-12-310001913577srt:ScenarioPreviouslyReportedMemberus-gaap:AdditionalPaidInCapitalMember2024-12-310001913577us-gaap:WarrantMember2026-01-012026-03-310001913577us-gaap:ResearchAndDevelopmentExpenseMember2026-01-012026-03-310001913577smnr:SponsorNoteMembersmnr:SatisfactionAndDischargeOfIndebtednessAgreementMember2026-01-012026-03-310001913577smnr:ShahAssignmentAgreementMembersmnr:NetSalesForAnnualNetSalesAtTheRateOfOnePointFivePercentageMember2013-08-060001913577srt:ScenarioPreviouslyReportedMember2024-12-310001913577us-gaap:PreferredStockMember2024-12-310001913577smnr:CumulativeNetSalesSevenHundredAndFiftyMillionDollarsMembersmnr:LegacySemnurMergerAgreementMember2019-03-180001913577smnr:ScilexHoldingCompanyMembersmnr:LegacySemnurStockOptionsMember2026-01-012026-03-310001913577us-gaap:EmployeeStockOptionMember2025-12-310001913577smnr:ScilexHoldingCompanyMemberus-gaap:EmployeeStockOptionMember2026-01-012026-03-310001913577smnr:LegacySemnurMergerAgreementMembersmnr:CumulativeNetSalesOneHundredMillionDollarsMember2019-03-182019-03-180001913577smnr:LegacySemnurMergerAgreementMembersmnr:CumulativeNetSalesOneHundredMillionDollarsMember2019-03-180001913577us-gaap:CommonStockMembersmnr:ConsultingServicesAgreementWithWiseOrientInvestmentsLimitedMember2025-07-222025-07-220001913577us-gaap:CommonStockMembersmnr:BitcoinSecuritiesPurchaseAgreementMember2025-09-232025-09-230001913577smnr:StockBasedCompensationMembersmnr:ScilexHoldingCompanyMember2025-01-012025-03-310001913577smnr:MergerAgreementMember2026-01-012026-03-310001913577smnr:DebtExchangeAgreementMembersmnr:ScilexHoldingCompanyMember2024-08-300001913577smnr:MergerAgreementMembersmnr:UnderwritersMember2025-09-222025-09-220001913577us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2024-12-310001913577smnr:TransitionServicesAgreementMembersmnr:ScilexHoldingCompanyMember2026-03-310001913577smnr:ExpensesPaidMembersmnr:ScilexHoldingCompanyMember2025-01-012025-03-310001913577smnr:SponsorNoteMember2025-12-3100019135772025-01-012025-03-310001913577us-gaap:ResearchAndDevelopmentExpenseMember2025-01-012025-03-310001913577us-gaap:CommonStockMember2025-03-310001913577us-gaap:WarrantMember2025-01-012025-03-310001913577us-gaap:EmployeeStockOptionMember2026-01-012026-03-310001913577smnr:ConsultingServicesAgreementWithJWInvestmentManagementCompanyLimitedMember2026-01-012026-03-310001913577smnr:TwoThousandTwentyFourStockOptionPlanMember2024-08-302024-08-300001913577us-gaap:SeriesAPreferredStockMember2026-03-310001913577smnr:TwoThousandTwentyFiveEquityIncentivePlanMember2025-11-172025-11-170001913577us-gaap:RetainedEarningsMember2025-03-310001913577srt:RestatementAdjustmentMemberus-gaap:AdditionalPaidInCapitalMember2024-12-3100019135772025-03-310001913577us-gaap:CommonClassBMember2026-01-012026-03-310001913577us-gaap:CommonStockMembersmnr:StockIssuanceAgreementWithLawFirmMember2025-07-222025-07-220001913577smnr:FutureTechNoteMembersmnr:SatisfactionAndDischargeOfIndebtednessAgreementMember2026-03-310001913577smnr:LegacySemnurCommonStockMember2026-03-310001913577us-gaap:CommonStockMembersmnr:DebtExchangeAgreementMembersmnr:ScilexHoldingCompanyMember2024-08-302024-08-300001913577smnr:MilestonesAchievementMembersmnr:LegacySemnurMergerAgreementMember2019-03-180001913577srt:MaximumMembersmnr:StockholderAgreementMember2026-01-012026-03-310001913577smnr:TwoThousandTwentyFourStockOptionPlanMember2024-08-300001913577smnr:TransitionServicesAgreementMembersmnr:ScilexHoldingCompanyMember2025-12-310001913577smnr:ScilexHoldingCompanyMemberus-gaap:CommonStockMembersmnr:DebtExchangeAgreementMember2025-09-222025-09-220001913577smnr:NewDrugApplicationFirstApprovalMembersmnr:LegacySemnurMergerAgreementMember2019-03-180001913577smnr:FutureTechNoteMembersmnr:SatisfactionAndDischargeOfIndebtednessAgreementMember2026-01-012026-03-310001913577smnr:LifecoreMasterServicesAgreementMember2026-01-012026-03-310001913577smnr:RetainedSharesMember2025-01-012025-03-310001913577srt:MinimumMember2026-03-310001913577us-gaap:EmployeeStockOptionMember2026-03-310001913577smnr:LegacySemnurMergerAgreementMembersmnr:CumulativeNetSalesFiveHundredMillionDollarsMember2019-03-182019-03-180001913577smnr:SponsorMember2025-09-220001913577smnr:MergerAgreementMembersmnr:ConsultantsMember2025-09-222025-09-220001913577us-gaap:WarrantMember2026-01-012026-03-310001913577us-gaap:CommonStockMember2026-03-310001913577smnr:LegacySemnurCommonStockMembersmnr:ScilexHoldingCompanyMember2026-01-012026-03-310001913577smnr:TwoThousandTwentyFiveEmployeeStockPurchasePlanMember2025-11-172025-11-170001913577us-gaap:PreferredStockMember2025-03-310001913577smnr:ScilexHoldingCompanyMember2026-01-012026-03-310001913577smnr:TwoThousandTwentyFiveInducementPlanMember2025-11-170001913577us-gaap:ComputerEquipmentMember2026-03-310001913577smnr:SponsorNoteMembersrt:MaximumMember2026-01-012026-03-3100019135772026-01-012026-03-310001913577smnr:TwoThousandTwentyFourStockOptionPlanMember2026-03-310001913577smnr:BitcoinSecuritiesPurchaseAgreementMember2026-03-310001913577us-gaap:WarrantMember2026-03-310001913577smnr:ScilexHoldingCompanyMember2025-09-220001913577smnr:ExpensesPaidMembersmnr:ScilexHoldingCompanyMember2026-01-012026-03-310001913577us-gaap:CommonStockMembersmnr:ConsultingServicesAgreementWithWiseOrientInvestmentsLimitedMember2026-01-012026-03-310001913577us-gaap:AdditionalPaidInCapitalMember2026-03-310001913577smnr:ScilexHoldingCompanyMemberus-gaap:CommonStockMember2025-09-222025-09-220001913577us-gaap:WarrantMember2026-01-012026-03-310001913577smnr:PIPESecuritiesPurchaseAgreementMember2025-12-310001913577us-gaap:CommonStockMembersmnr:ConsultingServicesAgreementWithJWInvestmentManagementCompanyLimitedMember2025-06-122025-06-120001913577smnr:SponsorNoteMembersrt:MinimumMember2026-01-012026-03-310001913577smnr:LegacySemnurMergerAgreementMembersmnr:CumulativeNetSalesFiveHundredMillionDollarsMember2019-03-180001913577smnr:ScilexHoldingCompanyMemberus-gaap:CommonStockMember2026-01-012026-03-310001913577smnr:TransitionServicesAgreementMembersrt:MaximumMembersmnr:ScilexHoldingCompanyMember2025-09-222025-09-220001913577smnr:PIPESecuritiesPurchaseAgreementMemberus-gaap:CommonStockMember2025-08-202025-08-200001913577us-gaap:CommonStockMembersrt:ScenarioPreviouslyReportedMember2024-12-310001913577us-gaap:PreferredStockMember2025-12-310001913577smnr:BitcoinSecuritiesPurchaseAgreementMember2025-12-310001913577us-gaap:WarrantMember2025-12-310001913577us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001913577smnr:ConsultingServicesAgreementWithJWInvestmentManagementCompanyLimitedMember2025-06-122025-06-120001913577smnr:DenaliCapitalGlobalInvestmentsLLCMember2025-09-220001913577smnr:InducementPlanMember2026-03-310001913577smnr:SponsorNoteMembersmnr:SatisfactionAndDischargeOfIndebtednessAgreementMember2026-03-310001913577smnr:ScilexHoldingCompanyMember2025-01-012025-03-3100019135772026-03-310001913577smnr:TwoThousandTwentyFiveEquityIncentivePlanMember2025-11-170001913577smnr:MergerAgreementMember2025-09-222025-09-220001913577smnr:InducementPlanMember2025-12-310001913577smnr:DenaliUnderwriterNotesMembersmnr:SatisfactionAndDischargeOfIndebtednessAgreementMember2026-01-012026-03-310001913577srt:RestatementAdjustmentMember2024-12-310001913577smnr:TransitionServicesAgreementMembersmnr:ScilexHoldingCompanyMember2025-09-222025-09-220001913577us-gaap:CommonStockMembersmnr:SponsorMember2025-09-222025-09-220001913577smnr:MergerAgreementMembersmnr:SponsorMember2025-09-222025-09-220001913577us-gaap:ConstructionInProgressMember2026-03-310001913577smnr:SponsorNoteMember2025-01-012025-12-310001913577smnr:SponsorMember2025-09-222025-09-220001913577smnr:SponsorNoteMember2026-03-310001913577smnr:ConsultingServicesAgreementWith450W42NDMIMALLCMember2025-09-012025-09-3000019135772025-12-310001913577smnr:SponsorNoteMember2026-01-012026-03-310001913577smnr:ShahAssignmentAgreementMembersmnr:NetSalesForAnnualNetSalesAtTheRateOfTwoPointFivePercentageMember2013-08-060001913577srt:MaximumMember2026-03-310001913577smnr:ScilexHoldingCompanyMemberus-gaap:SeriesAPreferredStockMembersmnr:DebtExchangeAgreementMember2025-09-222025-09-220001913577smnr:FutureTechNoteMember2025-12-310001913577smnr:ConsultingServicesAgreementWith450W42NDMIMALLCMember2025-07-222025-07-220001913577smnr:DenaliUnderwriterNotesMember2026-03-310001913577smnr:ShahAssignmentAgreementMembersmnr:NetSalesForAnnualNetSalesAtTheRateOfTwoPointFivePercentageMember2013-08-062013-08-060001913577us-gaap:CommonStockMembersrt:RestatementAdjustmentMember2024-12-310001913577smnr:MergerAgreementMembersmnr:DenaliPublicShareholdersMember2025-09-222025-09-220001913577smnr:RetainedSharesMember2026-01-012026-03-310001913577us-gaap:CommonStockMember2026-01-012026-03-310001913577smnr:PIPESecuritiesPurchaseAgreementMember2026-03-310001913577us-gaap:RetainedEarningsMembersrt:RestatementAdjustmentMember2024-12-310001913577smnr:MergerAgreementMembersmnr:DenaliUnderwritersMember2025-09-222025-09-220001913577smnr:CumulativeNetSalesSevenHundredAndFiftyMillionDollarsMembersmnr:LegacySemnurMergerAgreementMember2019-03-182019-03-180001913577us-gaap:ComputerEquipmentMember2025-12-310001913577us-gaap:RetainedEarningsMember2026-03-310001913577us-gaap:AdditionalPaidInCapitalMember2025-03-310001913577smnr:LegacySemnurCommonStockMembersrt:RestatementAdjustmentMember2024-12-310001913577us-gaap:GeneralAndAdministrativeExpenseMember2025-01-012025-03-3100019135772024-12-310001913577us-gaap:AdditionalPaidInCapitalMember2025-12-310001913577us-gaap:CommonStockMembersmnr:ConsultingServicesAgreementWithJWInvestmentManagementCompanyLimitedMember2025-07-222025-07-220001913577smnr:SatisfactionAndDischargeOfIndebtednessAgreementMember2026-03-310001913577us-gaap:CommonStockMembersmnr:StockIssuanceAgreementWithLawFirmMember2026-01-012026-03-310001913577us-gaap:CommonStockMember2024-12-3100019135772026-04-250001913577smnr:LegacySemnurCommonStockMember2025-12-310001913577us-gaap:SeriesAPreferredStockMember2025-12-310001913577us-gaap:GeneralAndAdministrativeExpenseMember2026-01-012026-03-310001913577smnr:CumulativeNetSalesTwoHundredAndFiftyMillionDollarsMembersmnr:LegacySemnurMergerAgreementMember2019-03-1800019135772025-01-012025-12-310001913577smnr:LegacySemnurCommonStockMembersrt:ScenarioPreviouslyReportedMember2024-12-310001913577us-gaap:ConstructionInProgressMember2025-12-310001913577smnr:LegacySemnurCommonStockMember2025-03-310001913577us-gaap:PreferredStockMembersrt:ScenarioPreviouslyReportedMember2024-12-310001913577us-gaap:RetainedEarningsMember2025-01-012025-03-31xbrli:purexbrli:sharessmnr:Segmentiso4217:USDiso4217:USDxbrli:shares\n\n \n\n \n\nUNITED STATES\n\nSECURITIES AND EXCHANGE COMMISSION\n\nWASHINGTON, D.C. 20549\n\n \n\nFORM 10-Q\n\n \n\n(Mark One)\n\n☒\n\nQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the quarterly period ended March 31, 2026\n\nOR\n\n☐\n\nTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\nFor the transition period from to\n\nCommission File Number: 001-41351\n\n \n\nSemnur Pharmaceuticals, Inc.\n\n(Exact Name of Registrant as Specified in its Charter)\n\n \n\n \n\nDelaware\n\n98-1659463\n\n(State or other jurisdiction of\n\nincorporation or organization)\n\n(I.R.S. Employer\nIdentification No.)\n\n960 San Antonio Road\n\nPalo Alto, CA\n\n94303\n\n(Address of principal executive offices)\n\n(Zip Code)\n\nRegistrant’s telephone number, including area code: (650) 422-7515\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\nTitle of each class\n\n \n\nTrading\n\nSymbol(s)\n\n \n\nName of each exchange on which registered\n\nCommon stock, par value $0.0001 per share\n\n \n\nSMNR\n\n \n\n*\n\nWarrants to purchase one share of common stock, each at an exercise price of $11.50 per share\n\n \n\nSMNRW\n\n \n\n*\n\n* On April 16, 2025, the registrant’s securities were suspended from trading on The Nasdaq Capital Market. On April 17, 2025, the registrant’s securities began trading on the OTCQB marketplace maintained by the OTC Markets Group, Inc. under the symbols “DNQAF”, “DNQWF” and “DNQUF.” In connection with the domestication and business combination discussed herein, on September 23, 2025, registrant’s securities began trading on the OTCQB marketplace maintained by the OTC Markets Group, Inc. under the symbols “SMNR” and “SMNRW”.\n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐\n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐\n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer\n\n☐\n\nAccelerated filer\n\n☐\n\nNon-accelerated filer\n\n☒\n\nSmaller reporting company\n\n☒\n\nEmerging growth company\n\n \n\n☒\n\n \n\n \n\n \n\n \n\n \n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒\n\nAs of April 25, 2026, the registrant had 230,209,142 shares of common stock outstanding.\n \n\n \n\n \n\n \n\n# INDEX TO FINANCIAL STATEMENTS\n\n# SEMNUR PHARMACEUTICALS, INC.\n\n \n\n \n\n \n\nPage\n\n \n\n \n\n \n\nPART I.\n\n[FINANCIAL INFORMATION](#part_i_financial_information)\n\n1"}